ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
46 announcements with these filters
Rainbow Childrens Medicare delivered its highest quarterly revenue and 20% YoY growth despite significant recent bed capacity additions. Management transitions are smooth with a focus on improving occupancies and clinical excellence.
Rainbow Childrens Medicare re-appointed four directors, including its MD and Chairperson, for five-year terms. These leadership extensions ensure management continuity and governance stability for investors.
Rainbow Children's Medicare approved its FY26 audited results and recommended a ₹3.50 per share dividend. Key leadership re-appointments were also cleared during the board meeting.
Rainbow Children's Medicare granted 2,67,550 stock options to employees under its ESOP Scheme 2025. This long-term incentive program aligns employee interests with shareholder value creation.
Rainbow Children’s Medicare Limited reported strong Q4 FY26 performance with 24% YoY revenue growth and 26% EBITDA growth. Strategy focuses on deepening the 'Hub and Spoke' model across major Indian cities.
Rainbow Childrens Medicare recommended a final dividend of Rs. 3.50 per share for FY2026. The record date is July 21, 2026, with payment by August 27.
Rainbow Children’s Medicare reported strong Q4 results with 24.3% revenue growth. The company completed its capacity expansion phase, shifting focus to execution and operational optimization.
Rainbow Childrens Medicare Ltd reported revenue from operations of ₹459.9 Cr (+24.3% YoY) and net profit of ₹78.2 Cr (+38.2% YoY) for Q4 FY26.
Rainbow Childrens Medicare reported audited FY26 results and recommended a ₹35.55 Crore final dividend. The board also approved several key director re-appointments for five-year terms.
Rainbow Children's Medicare Limited submitted its Annual Secretarial Compliance Report for the fiscal year 2026. The report confirms overall regulatory adherence with no material non-compliances noted.
Rainbow Children’s Medicare received an order upholding a prior GST demand notice. The company is now preparing an appeal before the appropriate higher authority.
Rainbow Children’s Medicare Limited inaugurated a new 60-bed spoke hospital and a dedicated IVF centre in Bengaluru for ₹52 Crore. Funded through internal accruals, this expansion increases the company's total bed capacity to ~2,435 beds. The facilities strengthen Rainbow's hub-and-spoke network in high-growth Karnataka micro-markets.
White Oak Capital Management Consultants LLP sold 20,38,948 shares (2.01%) of Rainbow Children's Medicare Ltd. This disposal follows a business transfer and reduces their total holding from 4.81% to 2.80%.
Rainbow Children's Medicare Ltd clarified to the BSE that the recent movement in its trading volume is market-driven. The company confirmed it has no undisclosed material information or unpublished price-sensitive information (UPSI) that could impact price or volume behavior, maintaining its commitment to regulatory compliance.
Rainbow Children's Medicare clarified that recent significant trading volume movements are market-driven and not due to any undisclosed material information. The company confirmed compliance with SEBI listing regulations and reiterated that no unpublished price-sensitive information exists.
Rainbow Children's Medicare Limited submitted its quarterly compliance certificate under SEBI (Depositories and Participants) Regulations for the period ended March 31, 2026. The RTA, KFIN Technologies, confirmed compliance regarding the dematerialization and rematerialization of securities.